BIONPHARMA INC FDA Approval NDA 021855

NDA 021855

BIONPHARMA INC

FDA Drug Application

Application #021855

Documents

Letter2005-08-08
Review2007-06-04
Label2005-08-08
Letter2017-03-14
Label2017-03-16
Letter2019-07-15
Label2019-07-15
Letter2020-06-24

Application Sponsors

NDA 021855BIONPHARMA INC

Marketing Status

Over-the-counter001
Over-the-counter002

Application Products

001CAPSULE;ORAL1MG1LOPERAMIDE HYDROCHLORIDELOPERAMIDE HYDROCHLORIDE
002CAPSULE;ORAL2MG1LOPERAMIDE HYDROCHLORIDELOPERAMIDE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2005-08-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2015-12-11STANDARD
LABELING; LabelingSUPPL6AP2017-03-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2019-01-31N/A
LABELING; LabelingSUPPL14AP2020-06-22STANDARD

Submissions Property Types

ORIG1Null31
SUPPL5Null0
SUPPL6Null15
SUPPL14Null15

CDER Filings

BIONPHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21855
            [companyName] => BIONPHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LOPERAMIDE HYDROCHLORIDE","activeIngredients":"LOPERAMIDE HYDROCHLORIDE","strength":"1MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"Yes","rs":"No"},{"drugName":"LOPERAMIDE HYDROCHLORIDE","activeIngredients":"LOPERAMIDE HYDROCHLORIDE","strength":"2MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"01\/31\/2019","submission":"SUPPL-9","supplementCategories":"Manufacturing (CMC)-Packaging","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021855Orig1s009lbl.pdf\"}]","notes":""},{"actionDate":"03\/09\/2017","submission":"SUPPL-6","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/021855Orig1s006lbl.pdf\"}]","notes":""},{"actionDate":"08\/04\/2005","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021855lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"LOPERAMIDE HYDROCHLORIDE","submission":"LOPERAMIDE HYDROCHLORIDE","actionType":"1MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">Yes"},{"actionDate":"LOPERAMIDE HYDROCHLORIDE","submission":"LOPERAMIDE HYDROCHLORIDE","actionType":"2MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-01-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.